Revenue segments as reported by the company.

Subscription services

Professional services and other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

General and admin

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Veeva Systems

Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007, and is headquartered in Pleasanton, CA.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Veeva Systems reports robust Q1 earnings, eyes growth opportunities

Veeva Systems delivered strong financial performance in Q1 2023, driven by robust execution and competitive wins. The company's focus on innovation, AI capabilities, and the transition to Vault CRM presents significant growth opportunities. However, challenges in the funding environment and customer migrations pose potential hurdles.

Veeva exceeds Q2 expectations, anticipates growth in clinical and data business

Veeva's Q2 performance exceeded expectations, leading to an increase in full-year guidance. The company's strengths lie in strong clinical activity, customer wins, and a focus on product excellence. However, challenges include migration costs, competitive landscape considerations, and marketing spend scrutiny. Veeva sees opportunities in M&A, minimal impact from R&D trends, and expansion of Veeva Link.

Veeva Systems surpasses Q3 expectations, eyes clinical data opportunity

Veeva Systems delivered a strong Q3 performance, with solid revenue and operating income. While facing challenges in billings and macroeconomic uncertainties, the company remains confident in its revenue target for fiscal year '25. The commitment from major enterprises and the potential in clinical data present significant opportunities for future growth.

Veeva Systems reports strong Q4 performance and forecasts $2.8B revenue

Veeva Systems showcases strong performance and strategic planning with revenue growth expectations of at least 15% in fiscal '24 and '25.
Positive feedback on product transitions and development, along with specialized sales teams, highlights market acceptance and innovation.
Challenges include short-term revenue impacts from timing-related issues and macro environment effects on customer spending.
Opportunities lie in revenue growth forecasts, product innovation, and market differentiation through new offerings and strategic deals.

Veeva Systems reports robust Q1 revenue growth and strategic focus

Veeva Systems' Q1 performance reflects strong revenue growth and a focus on customer-centric innovation. The company faces challenges in project scrutiny and competition but has opportunities in new product monetization and segment expansion.

Veeva Systems excels in Q2, eyes disciplined growth and innovation

Veeva Systems showcased robust financial performance, exceeding revenue and operating income targets, with a strong focus on customer success and product excellence.
While facing challenges such as migration costs and regulatory impacts, Veeva is well-positioned to leverage opportunities in disciplined M&A and product innovation.
The company's strategic growth initiatives, including Veeva Link expansion and CRM platform enhancements, aim to drive continued success and value for customers.

Veeva Systems posts solid Q3 results, eyes growth opportunities

Veeva Systems delivered a strong Q3 performance with solid revenue and operating income, showcasing financial stability and growth potential.
Despite challenges like trimmed billings and deal delays, Veeva remains confident in its fiscal year '25 revenue target, emphasizing strategic focus and operational efficiency.
The company's strengths in innovative products, strong partnerships, and global support ecosystem position it well for future growth and market leadership.
Opportunities in customer migration, AI integration, and market demand present avenues for Veeva to drive revenue growth and enhance its competitive positioning in the industry.

Veeva Systems excels in Q4 earnings, poised for strategic growth

Veeva Systems delivered strong financial performance in Q4 2024, showcasing revenue growth, operating income efficiency, and strategic product advancements.
The company's focus on innovation, customer success, and disciplined financial guidance positions it well for future growth and market leadership.
While facing challenges related to market uncertainties and operational considerations, Veeva remains resilient and poised to capitalize on opportunities for expansion and differentiation.
Overall, Veeva's Q4 earnings call highlights a balanced approach to growth, operational excellence, and strategic decision-making in a dynamic business environment.

Veeva Systems beats Q1 guidance, lowers full-year outlook amid challenges

Veeva Systems had a strong start to the year, exceeding Q1 guidance but lowering full-year revenue outlook due to macro challenges.
The company's performance in margin, client adoption, and innovation remains robust, with a focus on stability and predictability amidst industry challenges.
Challenges include AI disruption impacting plans, lower revenue guidance, and delays in funding benefits due to global conflicts and interest rate sensitivity.
Opportunities lie in new client bases, EDC deals progress, and the potential growth of Vault Basics and Link products in the market.

Veeva Systems excels in Q2, eyes strategic growth opportunities

Veeva Systems delivered a strong Q2 performance with revenue of $676 million and non-GAAP operating income of $280 million, driven by product expansions and customer wins.
The company's strengths lie in its comprehensive clinical suite, customer comfort with CRM solutions, and the importance of professional services for customer success.
Challenges include short-term billing growth constraints and the need for continuous product excellence, while opportunities exist in data architecture enhancement and upcoming Investor Day insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CRM Bot and Voice Control deliver GenAI-powered assistance in Vault CRM MADRID and PLEASANTON, Calif. , Nov. 20, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Vault CRM Bot and Vault CRM Voice Control, two new GenAI capabilities in Vault CRM.

Veeva Announces AI in Vault CRM

PLEASANTON, Calif. , Nov. 19, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced its new cloud-based digital Hazard Analysis and Critical Control Point (HACCP) solution.

Veeva Announces New Digital Hazard Analysis and Critical Control Point (HACCP) Solution

Veeva Systems (VEEV) concluded the recent trading session at $213.68, signifying a +0.15% move from its prior day's close.

Veeva Systems (VEEV) Rises But Trails Market: What Investors Should Know

PLEASANTON, Calif. , Nov. 14, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its third quarter, which ended October 31, 2024, after market close on December 5, 2024.

Veeva to Release Fiscal 2025 Third Quarter Results on December 5, 2024

Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know

Top biopharma company selects the next generation of CRM for life sciences as its commercial foundation for future expansion and launches PLEASANTON, Calif. , Nov. 14, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Boehringer Ingelheim is the latest global top 20 biopharma company to commit to moving to Veeva Vault CRM.

Boehringer Ingelheim Commits to Veeva Vault CRM

Synchronizing sales and marketing improves outcomes, yet 65% of field engagements are not PLEASANTON, Calif. , Nov. 14, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today released its latest  Veeva Pulse Field Trends Report, showing connected sales and marketing engagement helps biopharmas balance healthcare professionals' (HCPs) need for deep scientific information on complex medicines as they become more time-constrained.

Veeva Pulse Data Shows New Science Calls for More Connected Engagement

VEEV's robust product portfolio raises optimism about the stock. However, stiff competition and escalating costs are concerning.

Reasons to Retain Veeva Systems Stock in Your Portfolio Now

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Is Veeva (VEEV) a Buy as Wall Street Analysts Look Optimistic?

In the latest trading session, Veeva Systems (VEEV) closed at $236.87, marking a +0.8% move from the previous day.

Veeva Systems (VEEV) Laps the Stock Market: Here's Why

Veeva (VEEV) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Veeva (VEEV) Surges 5.2%: Is This an Indication of Further Gains?

LIBERTYVILLE, Ill.--(BUSINESS WIRE)-- #biotech--Compliance Group Inc Announces Services Partnership with Veeva Systems to Enhance Implementation, Validation and Post-Implementation Services.

Compliance Group Announces Services Partnership with Veeva Systems to Enhance Implementation, Validation and Post-Implementation Services

Block

Zoom Video

Most of these stocks have been growing powerfully, and a few seem reasonably or attractively valued.

3 Millionaire-Maker Software-as-a-Service (SaaS) Stocks

Veeva Systems (VEEV) closed at $212.78 in the latest trading session, marking a +1.89% move from the prior day.

Why Veeva Systems (VEEV) Outpaced the Stock Market Today

Walgreens

VEEV partners with Walgreens to provide better patient outcomes to life sciences companies.

Veeva Systems Collaborates With Walgreens to Improve Patient Outcomes

Zacks.com users have recently been watching Veeva (VEEV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It

VEEV's robust product portfolio raises optimism about the stock. However, escalating costs are concerning.

Here's Why You Should Add Veeva Stock in Your Portfolio Now

The latest trading day saw Veeva Systems (VEEV) settling at $212.23, representing a -0.18% change from its previous close.

Veeva Systems (VEEV) Suffers a Larger Drop Than the General Market: Key Insights

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Boomi connector streamlines integration of third-party applications with Veeva, uniting content and data for seamless, end-to-end business processes.

Boomi Launches New Veeva Vault Connector to Simplify Application Integration in the Life Sciences Industry

Walgreens and Veeva Form Strategic Partnership

Brokers Suggest Investing in Veeva (VEEV): Read This Before Placing a Bet

The latest trading day saw Veeva Systems (VEEV) settling at $217.02, representing a -0.14% change from its previous close.

Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note

Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know

PLEASANTON, Calif. , Oct. 15, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will host its investor day virtually on Thursday, November 7, 2024.

News for Veeva Systems Stock (VEEV)